Unknown

Dataset Information

0

Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.

ABSTRACT: The 3C-like protease (3CL(pro)) of severe acute respiratory syndrome associated coronavirus (SARS-CoV) is vital for SARS-CoV replication and is a promising drug target. Structure based virtual screening of 308307 chemical compounds was performed using the computation tool Autodock 3.0.5 on a WISDOM Production Environment. The top 1468 ranked compounds with free binding energy ranging from -14.0 to -17.09 kcal mol(-1) were selected to check the hydrogen bond interaction with amino acid residues in the active site of 3CL(pro). Fifty-three compounds from 35 main groups were tested in an in vitro assay for inhibition of 3CL(pro) expressed by Escherichia coli. Seven of the 53 compounds were selected; their IC(50) ranged from 38.57±2.41 to 101.38±3.27 ?M. Two strong 3CL(pro) inhibitors were further identified as competitive inhibitors of 3CL(pro) with K(i) values of 9.11±1.6 and 9.93±0.44 ?M. Hydrophobic and hydrogen bond interactions of compound with amino acid residues in the active site of 3CL(pro) were also identified.

SUBMITTER: Nguyen TT 

PROVIDER: S-EPMC7126700 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation.

Nguyen Thi Thanh Hanh TT   Ryu Hwa-Ja HJ   Lee Se-Hoon SH   Hwang Soonwook S   Breton Vincent V   Rhee Joon Haeng JH   Kim Doman D  

Bioorganic & medicinal chemistry letters 20110316 10

The 3C-like protease (3CL(pro)) of severe acute respiratory syndrome associated coronavirus (SARS-CoV) is vital for SARS-CoV replication and is a promising drug target. Structure based virtual screening of 308307 chemical compounds was performed using the computation tool Autodock 3.0.5 on a WISDOM Production Environment. The top 1468 ranked compounds with free binding energy ranging from -14.0 to -17.09 kcal mol(-1) were selected to check the hydrogen bond interaction with amino acid residues i  ...[more]

Similar Datasets

Unknown Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library.
| S-EPMC8091729 | biostudies-literature
Unknown Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease.
| S-EPMC7202269 | biostudies-literature
Unknown Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease.
| S-EPMC533918 | biostudies-literature
Unknown Virtual Screening of Transmembrane Serine Protease Inhibitors.
| S-EPMC8410343 | biostudies-literature
Unknown Identification of Severe Acute Respiratory Syndrome Coronavirus-2 inhibitors through in silico structure-based virtual screening and molecular interaction studies.
| S-EPMC8420533 | biostudies-literature
Unknown Identification of two antiviral inhibitors targeting 3C-like serine/3C-like protease of porcine reproductive and respiratory syndrome virus and porcine epidemic diarrhea virus.
| S-EPMC7117380 | biostudies-literature
Unknown Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2.
| S-EPMC8466562 | biostudies-literature
Unknown Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
| S-EPMC2934678 | biostudies-literature
Unknown <i>In crystallo</i>-screening for discovery of human norovirus 3C-like protease inhibitors.
| S-EPMC7365090 | biostudies-literature
Unknown Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
| S-EPMC2242481 | biostudies-literature